📖#TAVR use increased substantially among patients <70, driven by those aged 60–69, while #SAVR remained predominant. #StructuralHeart Presented at #TCT2026 published in #JSCAI
➡️ www.jscai.org/article/S277...
➡️ www.jscai.org/article/S277...
Temporal Trends in Utilization and Early Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients Younger Than 70 Years
Transcatheter aortic valve replacement (TAVR) has expanded across surgical-risk categories;
utilization among younger patients remains insufficiently characterized. We evaluated
temporal trends in TAV...
www.jscai.org
November 3, 2026 at 6:26 PM
📖#TAVR use increased substantially among patients <70, driven by those aged 60–69, while #SAVR remained predominant. #StructuralHeart Presented at #TCT2026 published in #JSCAI
➡️ www.jscai.org/article/S277...
➡️ www.jscai.org/article/S277...
While in-hospital mortality after M-TEER doesn't diverge by sex, new data analysis finds that differences in contemporary practice and device utilization still exist. Dive into the full story for deeper insights!
www.tctmd.com/news/hospita...
#StructuralHeart #Mitralvalve
www.tctmd.com/news/hospita...
#StructuralHeart #Mitralvalve
In-Hospital Mortality After M-TEER Doesn’t Diverge by Sex
Women were, however, more likely to experience bleeding and cardiac tamponade and less likely to get an ICD/CRT-D device.
www.tctmd.com
August 12, 2026 at 8:29 PM
While in-hospital mortality after M-TEER doesn't diverge by sex, new data analysis finds that differences in contemporary practice and device utilization still exist. Dive into the full story for deeper insights!
www.tctmd.com/news/hospita...
#StructuralHeart #Mitralvalve
www.tctmd.com/news/hospita...
#StructuralHeart #Mitralvalve
Excited to share that two of our scientific abstracts have been accepted for presentation at TCT 2026 in San Diego!
Our accepted work focuses on two important areas of contemporary interventional and structural cardiology
#TCT2026 #InterventionalCardiology #Cardiology #PCI #structuralheart
Our accepted work focuses on two important areas of contemporary interventional and structural cardiology
#TCT2026 #InterventionalCardiology #Cardiology #PCI #structuralheart
August 9, 2026 at 11:46 PM
Excited to share that two of our scientific abstracts have been accepted for presentation at TCT 2026 in San Diego!
Our accepted work focuses on two important areas of contemporary interventional and structural cardiology
#TCT2026 #InterventionalCardiology #Cardiology #PCI #structuralheart
Our accepted work focuses on two important areas of contemporary interventional and structural cardiology
#TCT2026 #InterventionalCardiology #Cardiology #PCI #structuralheart
TRI CLIP!
doi.org/10.24875/REC...
#structuralheart #cathlab #triclip #regurgitation #cardiology #heartdisease #heartfailure
doi.org/10.24875/REC...
#structuralheart #cathlab #triclip #regurgitation #cardiology #heartdisease #heartfailure
March 7, 2025 at 3:57 PM
Heart Biotech's Yacoub Heart Valve®
YouTube video by Francis White
youtu.be
May 7, 2026 at 4:13 PM
Curious how it works? Why not come and talk to us at this year's London Biotechnology Show on Wednesday and Thursday next week, the 18th and 19th. We're in the startup showcase. #StructuralHeart #LivingValve #CardiacSurgery #RegenerativeMedicine #TissueEngineering #CardioSky londonbiotechshow.com
June 13, 2025 at 4:26 PM
Curious how it works? Why not come and talk to us at this year's London Biotechnology Show on Wednesday and Thursday next week, the 18th and 19th. We're in the startup showcase. #StructuralHeart #LivingValve #CardiacSurgery #RegenerativeMedicine #TissueEngineering #CardioSky londonbiotechshow.com
#JournalWatch #StructuralHeart
📌 RV-PA coupling ratio (TAPSE/PASP)
👥 444 patients with TR undergoing TTVR in the TriValve registry
👉 TAPSE/PASP ratio >0.406 and (surprisingly!) a decrease in ratio after TTVR associated with lower all-cause mortality
📌 RV-PA coupling ratio (TAPSE/PASP)
👥 444 patients with TR undergoing TTVR in the TriValve registry
👉 TAPSE/PASP ratio >0.406 and (surprisingly!) a decrease in ratio after TTVR associated with lower all-cause mortality
December 2, 2024 at 2:25 PM
#JournalWatch #StructuralHeart
📌 RV-PA coupling ratio (TAPSE/PASP)
👥 444 patients with TR undergoing TTVR in the TriValve registry
👉 TAPSE/PASP ratio >0.406 and (surprisingly!) a decrease in ratio after TTVR associated with lower all-cause mortality
📌 RV-PA coupling ratio (TAPSE/PASP)
👥 444 patients with TR undergoing TTVR in the TriValve registry
👉 TAPSE/PASP ratio >0.406 and (surprisingly!) a decrease in ratio after TTVR associated with lower all-cause mortality
Early haemodynamic valve deterioration after TAVI was associated with stroke, bioprosthetic valve dysfunction, and valve failure in this international multicentre registry.
#TAVI #StructuralHeart#TAVI
eurointervention.pcronline.com/article/prog...
#TAVI #StructuralHeart#TAVI
eurointervention.pcronline.com/article/prog...
July 1, 2026 at 2:27 PM
Early haemodynamic valve deterioration after TAVI was associated with stroke, bioprosthetic valve dysfunction, and valve failure in this international multicentre registry.
#TAVI #StructuralHeart#TAVI
eurointervention.pcronline.com/article/prog...
#TAVI #StructuralHeart#TAVI
eurointervention.pcronline.com/article/prog...
🔥NEW ISSUE OUT🔥
State-of-the-art on residual risk pharmacotherapy • Day-case PCI consensus • Aspirin discontinuation in ACS • 7-year COMPARE-ABSORB • PINNACLE-I • Novel TR spacer • PCR news & more.
#Cardiosky #PCI #StructuralHeart
eurointervention.pcronline.com/issue/volume...
State-of-the-art on residual risk pharmacotherapy • Day-case PCI consensus • Aspirin discontinuation in ACS • 7-year COMPARE-ABSORB • PINNACLE-I • Novel TR spacer • PCR news & more.
#Cardiosky #PCI #StructuralHeart
eurointervention.pcronline.com/issue/volume...
February 16, 2026 at 2:06 PM
🔥NEW ISSUE OUT🔥
State-of-the-art on residual risk pharmacotherapy • Day-case PCI consensus • Aspirin discontinuation in ACS • 7-year COMPARE-ABSORB • PINNACLE-I • Novel TR spacer • PCR news & more.
#Cardiosky #PCI #StructuralHeart
eurointervention.pcronline.com/issue/volume...
State-of-the-art on residual risk pharmacotherapy • Day-case PCI consensus • Aspirin discontinuation in ACS • 7-year COMPARE-ABSORB • PINNACLE-I • Novel TR spacer • PCR news & more.
#Cardiosky #PCI #StructuralHeart
eurointervention.pcronline.com/issue/volume...
Long-term outcomes after BE-TAVI appear independent of annular size. In 2,699 patients, mortality and BVF at 7 years were similar between small and large annuli.
#TAVI #StructuralHeart #cardiosky
eurointervention.pcronline.com/article/long...
#TAVI #StructuralHeart #cardiosky
eurointervention.pcronline.com/article/long...
November 27, 2025 at 2:31 PM
Long-term outcomes after BE-TAVI appear independent of annular size. In 2,699 patients, mortality and BVF at 7 years were similar between small and large annuli.
#TAVI #StructuralHeart #cardiosky
eurointervention.pcronline.com/article/long...
#TAVI #StructuralHeart #cardiosky
eurointervention.pcronline.com/article/long...
Redo-TAVI with a supra-annular, large-cell ACURATE valve for failed short-frame THVs offers potential haemodynamic and coronary access advantages. This initial clinical experience highlights key pre- and procedural considerations to optimise outcomes. shorturl.at/pHSoe
#TAVI #StructuralHeart
#TAVI #StructuralHeart
October 4, 2025 at 9:14 AM
Redo-TAVI with a supra-annular, large-cell ACURATE valve for failed short-frame THVs offers potential haemodynamic and coronary access advantages. This initial clinical experience highlights key pre- and procedural considerations to optimise outcomes. shorturl.at/pHSoe
#TAVI #StructuralHeart
#TAVI #StructuralHeart
In the bRIGHT EU PAS registry, tricuspid TEER with TriClip showed safety & efficacy even in patients with endocardial leads. TR reduction, QoL & NYHA class improved, with no CIED malfunctions.
👉 Read more: ow.ly/oq4n50Va9fo
#TTVI #TricuspidRegurgitation #CIED #StructuralHeart #cardiosky
👉 Read more: ow.ly/oq4n50Va9fo
#TTVI #TricuspidRegurgitation #CIED #StructuralHeart #cardiosky
March 14, 2025 at 3:03 PM
In the bRIGHT EU PAS registry, tricuspid TEER with TriClip showed safety & efficacy even in patients with endocardial leads. TR reduction, QoL & NYHA class improved, with no CIED malfunctions.
👉 Read more: ow.ly/oq4n50Va9fo
#TTVI #TricuspidRegurgitation #CIED #StructuralHeart #cardiosky
👉 Read more: ow.ly/oq4n50Va9fo
#TTVI #TricuspidRegurgitation #CIED #StructuralHeart #cardiosky
A successful double transcatheter valve replacement (mitral + tricuspid) using Tendyne and LuX-Valve in a high-risk patient.
When TEER is not an option, replacement may be the key.
#Tendyne #LuXValve #StructuralHeart #TVR #cardiosky
ow.ly/GgP150VeuO4
When TEER is not an option, replacement may be the key.
#Tendyne #LuXValve #StructuralHeart #TVR #cardiosky
ow.ly/GgP150VeuO4
March 10, 2025 at 4:40 PM
A successful double transcatheter valve replacement (mitral + tricuspid) using Tendyne and LuX-Valve in a high-risk patient.
When TEER is not an option, replacement may be the key.
#Tendyne #LuXValve #StructuralHeart #TVR #cardiosky
ow.ly/GgP150VeuO4
When TEER is not an option, replacement may be the key.
#Tendyne #LuXValve #StructuralHeart #TVR #cardiosky
ow.ly/GgP150VeuO4
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) #structuralheart disease #cardiology
Read here: eurointervention.pcronline.com/article/a-no...
Read here: eurointervention.pcronline.com/article/a-no...
January 31, 2025 at 2:26 PM
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) #structuralheart disease #cardiology
Read here: eurointervention.pcronline.com/article/a-no...
Read here: eurointervention.pcronline.com/article/a-no...
🚨 New Journal Launch! EHJ–Valvular and Structural Heart Disease is now open for submissions.
Share your research on:
✔️ Valve disease
✔️ Structural interventions
✔️ Advanced imaging
Submit your work: oxford.ly/49aOWKa
#Cardiology #StructuralHeart #HeartResearch
Share your research on:
✔️ Valve disease
✔️ Structural interventions
✔️ Advanced imaging
Submit your work: oxford.ly/49aOWKa
#Cardiology #StructuralHeart #HeartResearch
December 22, 2025 at 11:00 AM
🚨 New Journal Launch! EHJ–Valvular and Structural Heart Disease is now open for submissions.
Share your research on:
✔️ Valve disease
✔️ Structural interventions
✔️ Advanced imaging
Submit your work: oxford.ly/49aOWKa
#Cardiology #StructuralHeart #HeartResearch
Share your research on:
✔️ Valve disease
✔️ Structural interventions
✔️ Advanced imaging
Submit your work: oxford.ly/49aOWKa
#Cardiology #StructuralHeart #HeartResearch
Got insights into TAVR, mitral repair, or congenital interventions?
EHJ–Valvular and Structural Heart Disease wants your research: oxford.ly/3M9OS4t
#StructuralHeart #ValvularDisease #Cardiology
EHJ–Valvular and Structural Heart Disease wants your research: oxford.ly/3M9OS4t
#StructuralHeart #ValvularDisease #Cardiology
December 4, 2025 at 8:00 PM
Got insights into TAVR, mitral repair, or congenital interventions?
EHJ–Valvular and Structural Heart Disease wants your research: oxford.ly/3M9OS4t
#StructuralHeart #ValvularDisease #Cardiology
EHJ–Valvular and Structural Heart Disease wants your research: oxford.ly/3M9OS4t
#StructuralHeart #ValvularDisease #Cardiology
🫀 Can fixing functional MR improve outcomes in heart failure?
The RESHAPE-HF2 Trial (2024) says yes.
#Cardiology #HeartFailure #MitraClip #StructuralHeart
The RESHAPE-HF2 Trial (2024) says yes.
#Cardiology #HeartFailure #MitraClip #StructuralHeart
May 19, 2026 at 2:52 AM
🫀 Can fixing functional MR improve outcomes in heart failure?
The RESHAPE-HF2 Trial (2024) says yes.
#Cardiology #HeartFailure #MitraClip #StructuralHeart
The RESHAPE-HF2 Trial (2024) says yes.
#Cardiology #HeartFailure #MitraClip #StructuralHeart
🚀 If we start reporting even 3 of these opportunistic metrics (e.g. RV function, membranous septum length, frailty marker), we move CT-TAVR from procedural planning → phenotyping platform.
#TAVR #StructuralHeart #cardioSky @danilorenzatti @CardioMDPhD
#TAVR #StructuralHeart #cardioSky @danilorenzatti @CardioMDPhD
October 30, 2025 at 11:33 PM
🚀 If we start reporting even 3 of these opportunistic metrics (e.g. RV function, membranous septum length, frailty marker), we move CT-TAVR from procedural planning → phenotyping platform.
#TAVR #StructuralHeart #cardioSky @danilorenzatti @CardioMDPhD
#TAVR #StructuralHeart #cardioSky @danilorenzatti @CardioMDPhD
What do you think of the performance and calibration?
Try out the calculator here: www.eurotr.eu/etr
Great work by @j_hausleitern, @phillipplurz, and team!
Full manuscript: www.jacc.org/doi/10.1016/...
#CardioTwitter #CardioX #TTEER #TricuspidValve #StructuralHeart @JACCJournals #AI
Try out the calculator here: www.eurotr.eu/etr
Great work by @j_hausleitern, @phillipplurz, and team!
Full manuscript: www.jacc.org/doi/10.1016/...
#CardioTwitter #CardioX #TTEER #TricuspidValve #StructuralHeart @JACCJournals #AI
EuroTR
The EuroTR registry (NCT06307262) is an international, multicenter, retrospective European registry to assess safety and efficacy of tricuspid valve edge-to-edge repair/replacement in patients with…
www.eurotr.eu
March 11, 2026 at 10:14 PM
What do you think of the performance and calibration?
Try out the calculator here: www.eurotr.eu/etr
Great work by @j_hausleitern, @phillipplurz, and team!
Full manuscript: www.jacc.org/doi/10.1016/...
#CardioTwitter #CardioX #TTEER #TricuspidValve #StructuralHeart @JACCJournals #AI
Try out the calculator here: www.eurotr.eu/etr
Great work by @j_hausleitern, @phillipplurz, and team!
Full manuscript: www.jacc.org/doi/10.1016/...
#CardioTwitter #CardioX #TTEER #TricuspidValve #StructuralHeart @JACCJournals #AI
The semifinals are done! The Structural Heart semifinalists are Sergio Mellado Flores, MD and Ahmed Salama, MD. Congrats! Finals are Saturday at 12:15 in Salon 5. Come enjoy a box lunch and see all the finalist compete for $1000! #cardiology #competition #structuralheart #CVI2025
July 25, 2025 at 11:04 PM
The semifinals are done! The Structural Heart semifinalists are Sergio Mellado Flores, MD and Ahmed Salama, MD. Congrats! Finals are Saturday at 12:15 in Salon 5. Come enjoy a box lunch and see all the finalist compete for $1000! #cardiology #competition #structuralheart #CVI2025
The final semifinal of the Challenging Case Competition at #CVI2025 is going on right now. Here's some shots from earlier sessions. #fellows #competition #casebased #cardiology #structuralheart #CardioSky #MedSky
July 25, 2025 at 9:58 PM
The final semifinal of the Challenging Case Competition at #CVI2025 is going on right now. Here's some shots from earlier sessions. #fellows #competition #casebased #cardiology #structuralheart #CardioSky #MedSky
Why attend CVI? "Definitely recommend!" "Focused and to the point" "Best format of any meeting by far." CVI: The Operators Enclave - Register/Info at https://cvinnovations.org/cvi2025/
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
July 12, 2025 at 2:16 PM
Why attend CVI? "Definitely recommend!" "Focused and to the point" "Best format of any meeting by far." CVI: The Operators Enclave - Register/Info at https://cvinnovations.org/cvi2025/
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
CVI 2024 attendees say: "Definitely recommend!" "Focused and to the point" "Best format of any meeting by far." CVI: The Operators Enclave - Register/Info at https://cvinnovations.org/cvi2025/
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
July 7, 2025 at 12:00 AM
CVI 2024 attendees say: "Definitely recommend!" "Focused and to the point" "Best format of any meeting by far." CVI: The Operators Enclave - Register/Info at https://cvinnovations.org/cvi2025/
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
CVI 2024 attendees say: "Definitely recommend!" "Focused and to the point" "Best format of any meeting by far." CVI: The Operators Enclave - Register/Info at https://cvinnovations.org/cvi2025/
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
June 28, 2025 at 4:25 PM
CVI 2024 attendees say: "Definitely recommend!" "Focused and to the point" "Best format of any meeting by far." CVI: The Operators Enclave - Register/Info at https://cvinnovations.org/cvi2025/
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
#cme #conference #cardiology #cardiologist #aortic #coronary #structuralheart #CardioSky #MedSky
Countdown to #CVI2025 - Interviews from #CVI - Are We There Yet? TAVR for AR, with @chadialraies, MD, Nadira Hamid @HamidNadira, MD & Nicholas Amoroso, MD #cardiology #imaging #structuralheart #interview #CardioSky #MedSky #TAVR
https://youtu.be/DhI25dgjUCc
https://youtu.be/DhI25dgjUCc
Are We There Yet? TAVR for AR, with Chadi Alraies, MD, Nadira Hamid, MD & Nicholas Amoroso, MD
@ChadiAlraies talks with Dr. Nadira Hamid and Dr. Nicholas Amoroso about TAVR for AR in 2024 at CVI 2024 in Denver, CO. @hearttrendingwithchadi
youtu.be
June 21, 2025 at 3:15 PM
Countdown to #CVI2025 - Interviews from #CVI - Are We There Yet? TAVR for AR, with @chadialraies, MD, Nadira Hamid @HamidNadira, MD & Nicholas Amoroso, MD #cardiology #imaging #structuralheart #interview #CardioSky #MedSky #TAVR
https://youtu.be/DhI25dgjUCc
https://youtu.be/DhI25dgjUCc